Skip to main content

Table 1 Characteristics of study participants

From: Changes in glycemic variability, gastric emptying and vascular endothelial function after switching from twice-daily to once-weekly exenatide in patients with type 2 diabetes: a subpopulation analysis of the twin-exenatide study

N (male/female)

29 (28/1)

Age (years)

55 ± 12

Height (m)

1.68 ± 0.07

Weight (kg)

95.1 ± 32.7

BMI (kg/m2)

33.3 ± 10.6

Duration of diabetes (years)

12 ± 6

FPG (mg/dl)

164 ± 52

HbA1c (%)

7.4 ± 1.4

eGFR (ml/min/1.73m2)

75.1 ± 23.8

Hypertension (%)

86.2

Dyslipidemia (%)

72.4

CVD (%)

27.6

Concomitant anti-diabetic medication

 

None (%)

13.8

SU (%)

55.2

Metformin (%)

79.3

TZD (%)

24.1

AGI (%)

10.3

SGLT2 inhibitor (%)

6.9

  1. FPG fasting plasma glucose, eGFR estimated glomerular filtration rate, CVD cardiovascular disease, SU sulfonylurea, TZD thiazolidinedione, AGI α-glucosidase inhibitor, SGLT2 sodium-glucose cotransporter 2